BenevolentAI
verifiedPaidbenevolent.ai
AI drug-discovery platform using a biomedical knowledge graph to surface targets and speed R&D decisions.
What it does
BenevolentAI applies AI and machine learning to biopharma drug discovery. Built on a decade of investment in a biomedical knowledge graph and proprietary ontologies, it delivers 'life science intelligence' to help scientists and executives make faster, evidence-based R&D decisions.
Core features
Biomedical knowledge graph
Proprietary ontologies
AI target identification
Life science intelligence platform
R&D decision support
Best for
→Identify and prioritize drug targets
→Accelerate biopharma R&D decisions
→Mine biomedical data for insights
Reviews
Big-picture takes: what it's for and whether it delivers. High-engagement YouTube videos — not sponsored.